| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5209334
Max Phase: Preclinical
Molecular Formula: C19H23N5O2
Molecular Weight: 353.43
Associated Items:
Representations
Canonical SMILES: O=C(NC1CC1)NC1CCCN(C(=O)c2cc(-c3ccccc3)[nH]n2)C1
Standard InChI: InChI=1S/C19H23N5O2/c25-18(17-11-16(22-23-17)13-5-2-1-3-6-13)24-10-4-7-15(12-24)21-19(26)20-14-8-9-14/h1-3,5-6,11,14-15H,4,7-10,12H2,(H,22,23)(H2,20,21,26)
Standard InChI Key: WHOYYKKWAQVGRH-UHFFFAOYSA-N
Associated Targets(Human)
Lysine-specific demethylase 5B 814 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 353.43 | Molecular Weight (Monoisotopic): 353.1852 | AlogP: 2.14 | #Rotatable Bonds: 4 |
| Polar Surface Area: 90.12 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 10.79 | CX Basic pKa: 0.58 | CX LogP: 1.37 | CX LogD: 1.37 |
| Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.79 | Np Likeness Score: -1.97 |
References
| 1. Tang K, Jiao LM, Qi YR, Wang TC, Li YL, Xu JL, Wang ZW, Yu B, Liu HM, Zhao W.. (2022) Discovery of Novel Pyrazole-Based KDM5B Inhibitor TK-129 and Its Protective Effects on Myocardial Remodeling and Fibrosis., 65 (19.0): [PMID:36112701] [10.1021/acs.jmedchem.2c00797] |
Source
Source(1):